HMN 2025: How New study sheds light on gaps in post-hospital care for steroid-induced hyperglycemia

A recent study has revealed critical insights into the challenges faced by patients, families, and clinicians in managing steroid-induced hyperglycemia (SIH) after hospital discharge.

The research led by the University of Surrey and conducted at East Surrey Hospital, highlights the urgent need for improved care pathways, better communication, and the potential role of technology in supporting patients outside hospital settings.

Understanding the burden of SIH

SIH, a condition triggered by steroid treatment, often complicates diabetes management and poses a heightened risk of hypoglycemia as steroid doses taper post-discharge. Despite its prevalence, the study, published in Diabetic Medicine, found that experiences of managing SIH in the community is daunting.

The findings reveal widespread concern among patients and families about the risks of hypoglycemia and a lack of confidence in self-managing the condition—particularly among those with more than one health condition. Many reported receiving conflicting advice from different care teams and limited follow-up support.

Clinicians, especially in primary care, expressed difficulty in managing SIH due to capacity constraints, often leaving hospital teams to continue oversight, thereby increasing their workload. Communication gaps between care teams further compounded these challenges.

Recommendations for better care

The study recommends:

• Developing individual care plans for SIH.
• Enhancing training and communication across multidisciplinary teams.
• Ensuring consistent follow-up and providing patients with a clear point of contact.
• Providing technology to support self-management and care coordination.

“The next phase of the project involves securing additional funding to pilot and evaluate technology-enabled solutions for SIH management in community settings,” said Dr. Nyangi Gityamwi, ARC KSS Digital Innovation, Post-Doctoral Research Fellow at the University of Surrey.

Impact and next steps

The project has already begun to influence thinking and practice around the management of steroid-induced hyperglycemia (SIH) outside the hospital. Through patient interviews, clinician engagement, and public involvement workshops, the research has identified gaps in care continuity, communication, and patient empowerment.

The content is provided for information purposes only.